LYMPHA PRESS, U.S.A.
Lympha Press, U.S.A. is a privately held medical device company, founded in 1984 and based in Chadds Ford, Pennsylvania, that sells FDA-cleared pneumatic compression pumps and garments for at-home treatment of lymphedema, lipedema, chronic venous insufficiency, and chronic wounds, reimbursed through Medicare, Medicaid, private insurers, the VA, and direct patient sales.
- Company typePrivate
- Founded1984
- HeadquartersChadds Ford, United States
- Headcount—
- GTM typeB2C
- OfferingHardware or Manufacturing
What LYMPHA PRESS, U.S.A. does
Lympha Press, U.S.A. is a privately held medical device company founded in 1984 and headquartered in Chadds Ford, Pennsylvania, that develops and sells pneumatic compression therapy systems for the at-home treatment of lymphedema, lipedema, chronic venous insufficiency, and chronic wounds. Its core product platform is the Optimal Plus digitally-connected compression pump, paired with a family of trademarked garments — Lympha Pants, LymphaPod, ComfySleeve, and Lympha Jacket — that target different body areas and patient profiles using patented overlapping-chamber technology to reduce backflow during therapy. The company also offers a mobile application for iOS and Android that allows patients to configure and control therapy sessions, and the Optimal Plus system is FDA-cleared for the treatment of lipedema.
The company monetizes through hardware sales (compression pumps and garments), reimbursed claims submitted on behalf of patients under Medicare, Medicaid, private health plans, and Veterans Affairs coverage, and direct-to-patient sales supplemented by CareCredit financing. Its go-to-market combines a nationwide field force of compression therapy consultants and Territory Managers who work with prescribing clinicians, a dedicated insurance team that verifies coverage, and a direct-to-consumer channel with a secure patient pay portal. Lympha Press differentiates on the basis of more than 40 years of brand presence, 30+ peer-reviewed clinical publications, patented overlapping-chamber garment design, and high reported patient compliance (87% over two years, 90% would recommend). The company serves patients across 37 U.S. counties and supports a content and community ecosystem that includes monthly Lymphedema and Lipedema Patient Roundtables, educational webinars, and active presence across major social platforms.
LYMPHA PRESS, U.S.A. firmographics
Firmographics- Name
- LYMPHA PRESS, U.S.A.
- Legal name
- Lympha Press
- Website
- https://lymphapress.com
- Company type
- Private
- Founded year
- 1984
- Operating status
- Operating
- Short description
- Lympha Press, U.S.A. is a privately held medical device company, founded in 1984 and based in Chadds Ford, Pennsylvania, that sells FDA-cleared pneumatic compression pumps and garments for at-home treatment of lymphedema, lipedema, chronic venous insufficiency, and chronic wounds, reimbursed through Medicare, Medicaid, private insurers, the VA, and direct patient sales.
- Ownership category
- akta.pro rank
LYMPHA PRESS, U.S.A. industry classification
Industry- Product category
- Medical Compression Therapy Devices
- NAICS
- Measuring, Dispensing, and Other Pumping Equipment Manufacturing (333914)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
- akta.pro primary industry
- Compression Therapy & Lymphedema DME (Garments, Pneumatic Pumps) (HLAHAMAH)
- akta.pro secondary industries
- Lymphedema & Edema Therapy In-Home (HSABADAI), Compression Therapy (Normatec/Pressotherapy) (HSADAKAH)
Keywords
Where LYMPHA PRESS, U.S.A. is headquartered
LocationHeadquarters
- HQ city
- Chadds Ford
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
LYMPHA PRESS, U.S.A. business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- Compression Pump Sales: Sale of pneumatic compression pump devices for at-home therapy. The Optimal Plus pump serves as the primary device platform, compatible with various garments.
- Compression Garment Sales: Sale of therapeutic garments including Lympha Pants, ComfySleeve, LymphaPod, and upper body garments. Garments are sold as accessories and replacements for pump devices.
- Health Plan Reimbursement: Revenue from Medicare, Medicaid, private health plans, and Veterans Affairs coverage for compression therapy devices prescribed to patients with qualifying conditions.
- Patient Financing: Partnership with CareCredit to provide financing options for patients, enabling access to therapy products through installment payment plans.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Quote-based pricing through health plan verification and direct sales |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels6 records
LYMPHA PRESS, U.S.A. product offering
Product offeringCore offering
Lympha Press manufactures and sells pneumatic compression therapy systems for at-home treatment of lymphedema, lipedema, chronic venous insufficiency, chronic wounds, and related circulatory conditions. The core offering is the Optimal Plus digitally-connected compression pump, complemented by a line of therapeutic garments (Lympha Pants, LymphaPod, ComfySleeve, Lympha Jacket) that deliver clinically proven, FDA-cleared therapy tailored to patient conditions and lifestyles.
Product overview
Lympha Press is a medical device company offering pneumatic compression therapy systems for at-home treatment of lymphedema, lipedema, chronic venous insufficiency, wounds, and related circulatory conditions. The product portfolio consists of compression pumps (Optimal Plus, ArtAssist) and complementary compression garments (Lympha Pants, LymphaPod, ComfySleeve, Lympha Jacket) that work together as an integrated therapy system. The Optimal Plus pump serves as the core therapy device, connecting via a mobile app, while garments are selected based on patient body area and condition requirements—Lympha Pants for standard lower body, LymphaPod for larger patients with mobility limitations, and ComfySleeve/Lympha Jacket for upper body treatment. The system is backed by over 25 years of research and 30+ clinical trials, with products designed for ease of use to promote patient compliance.
Differentiator
Problem solved
Functional benefit
Brands
- LymphaPod: Home care compression system designed for larger patients with lymphedema, treating the entire lower body including legs, hips, and abdomen.
- Optimal Plus
- Lympha Pants
- ComfySleeve
Products and services
- Optimal Plus Digitally-connected pneumatic compression pump for at-home treatment of lymphedema, lipedema, chronic venous insufficiency, and other circulatory conditions, with customizable therapy programs and clinically proven efficacy.
- Lympha Pants Lower body compression garment treating the abdomen, buttocks, genitals, inguinal areas, feet, and legs, designed for patients with swelling in proximal areas as well as feet and legs.
- LymphaPod One-size lower body compression garment designed specifically for larger patients with limited mobility, treating the entire lower body including abdomen, lower back, hips, and genital area with 40 overlapping chambers.
- ComfySleeve Upper body compression garment that can treat the arm, chest, shoulder, back, and abdomen, with calibrated pressure for different body areas and conditions including edema, lymphedema, fibrosis, and post-procedure sensitivity.
- Lympha Jacket Upper body compression garment for treating the torso, arms, and upper body lymphedema as part of the upper body garment line for patients requiring chest and arm compression therapy.
- ArtAssist Compression therapy system for clinician use, representing an alternative or additional therapy device offering within the Lympha Press product portfolio for healthcare providers.
- Lympha Press Mobile App Mobile application for Android, iPhone, and tablets that enables patients to control and configure their compression therapy sessions, used with the Optimal Plus pump and LymphaPod.
Quantifiable outcome
- 87% of patients remained compliant with Lympha Press treatment during the first two years of use
- +10 more outcomes
Companies that use LYMPHA PRESS, U.S.A.
Customer profileNamed customers3 records
Segments6 records
Ideal customer profiles4 records
LYMPHA PRESS, U.S.A. technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration4 records
Feature6 records
LYMPHA PRESS, U.S.A. partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and supporting.
- MedicarecoreMedicare coverage for Lympha Press pneumatic compression therapy devices for eligible patients with lymphedema and related conditions. The company works directly with Medicare to ensure coverage for prescribed therapy.
- MedicaidcoreMedicaid coverage partnerships providing access to compression therapy for patients with qualifying conditions across state Medicaid programs.
- Private Health PlanscorePartnerships with private health insurance plans to provide coverage for compression therapy devices. The company employs a dedicated insurance team to work with carriers on coverage verification.
- Veterans Affairs (VA)coreVA coverage for compression therapy serving veterans with lymphedema and related conditions. Dedicated program for serving veterans mentioned on the company website.
- Franklin and Marshall College - Center for Opinion ResearchsupportingIndependent research partnership conducting statistically valid patient surveys to measure treatment outcomes and patient satisfaction with Lympha Press therapy.
Scale indicators10 records
Recent moves6 records
Expansion highlights5 records
LYMPHA PRESS, U.S.A. competitors and assessment
Company assessmentDirect peers
- Bio Compression Systems: Bio Compression Systems manufactures pneumatic compression pumps and sleeves for lymphedema, venous insufficiency, and wound care. It competes head-to-head with Lympha Press in the U.S. clinical and DME channels, offering comparable therapy modalities and reimbursement-backed distribution.
- Tactile Medical: Tactile Medical is the publicly-traded U.S. leader in at-home pneumatic compression therapy for lymphedema and chronic venous insufficiency, with its flagship Flexitouch system. It is the most direct competitor to Lympha Press's Optimal Plus, targeting the same patient population, prescriber base, and payer reimbursement channels.
- Devon Medical: Devon Medical manufactures and distributes pneumatic compression therapy and DVT prevention devices. It competes with Lympha Press in the home-use and clinical lymphedema segment, with overlapping reimbursement and clinician-referral channels.
- AIROS Medical: AIROS Medical produces pneumatic compression devices for lymphedema and related conditions, including the AIROS 6 and AIROS 8 sequential compression systems. It is a direct competitor in the same at-home therapy reimbursement category and serves a similar clinician and patient channel.
Broad incumbents
- Enovis (DJO / Chattanooga): Enovis (formerly DJO, including Chattanooga) is a large orthopedic and rehabilitation medical device company offering compression therapy and vascular treatment devices. While broader in scope, it competes with Lympha Press in the DME and rehabilitation channels and has substantially greater commercial reach.
- BTL Industries: BTL is a global medical device manufacturer with a portfolio spanning aesthetics, physical therapy, and rehabilitation including compression-related modalities. It is a broad incumbent rather than a direct lymphedema specialist, but its scale and R&D resources make it a relevant adjacent competitor.
- Arjo (Huntleigh): Arjo, through its Huntleigh brand, offers a broad portfolio of DVT and lymphatic compression therapy devices sold to hospitals and homecare providers. While not U.S.-specialized in lymphedema, it competes in adjacent compression therapy categories and brings substantially greater scale and distribution.
Emerging players
- Hyperice (Normatec): Hyperice's Normatec line popularized consumer pneumatic compression for recovery and wellness. While historically positioned for athletic recovery rather than clinical lymphedema, the brand has expanded into medical-adjacent indications and represents a consumer-channel threat to Lympha Press's DTC patient market.
- Koya Medical: Koya Medical develops next-generation compression therapy devices for lymphedema and venous disease, including a wearable, app-connected segmental compression system. It is an emerging competitor targeting the same patient population with a more mobile, consumer-friendly form factor.
Regional players
- Mego Afek (Lymphapress International): Mego Afek is the Israeli manufacturer of Lympha Press systems internationally and is closely associated with the Lympha Press brand outside the U.S. It operates the same underlying technology in Europe and other markets, making it a regional category peer and a likely sister entity within the broader Lympha Press product family.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks5 records
Key highlights6 records
Customer concentration
LYMPHA PRESS, U.S.A. social profiles
Digital presenceLYMPHA PRESS, U.S.A. compliance and trust
Trust signalCompliance1 record
LYMPHA PRESS, U.S.A. financial estimates
Financial estimateRevenue estimate
Valuation estimate
LYMPHA PRESS, U.S.A. leadership team
Management profileNumber of profiles
Profiles1 record
LYMPHA PRESS, U.S.A. funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
LYMPHA PRESS, U.S.A. M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about LYMPHA PRESS, U.S.A.
What does LYMPHA PRESS, U.S.A. do?
Lympha Press manufactures and sells pneumatic compression therapy systems for at-home treatment of lymphedema, lipedema, chronic venous insufficiency, chronic wounds, and related circulatory conditions. The core offering is the Optimal Plus digitally-connected compression pump, complemented by a line of therapeutic garments (Lympha Pants, LymphaPod, ComfySleeve, Lympha Jacket) that deliver clinically proven, FDA-cleared therapy tailored to patient conditions and lifestyles.
Is LYMPHA PRESS, U.S.A. a public or private company?
LYMPHA PRESS, U.S.A. is a private company. It is classified as unknown and is currently operating.
When was LYMPHA PRESS, U.S.A. founded?
LYMPHA PRESS, U.S.A. was founded in 1984.
Where is LYMPHA PRESS, U.S.A. based?
LYMPHA PRESS, U.S.A. is headquartered in Chadds Ford, United States, in the North America region.
How does LYMPHA PRESS, U.S.A. make money?
Four revenue lines are on record. Compression Pump Sales are the primary driver. The others are compression Garment Sales, health Plan Reimbursement and patient Financing.
Who are LYMPHA PRESS, U.S.A.'s main competitors?
Direct peers on record are Bio Compression Systems, Tactile Medical, Devon Medical and AIROS Medical. Broad incumbents are Enovis (DJO / Chattanooga), BTL Industries and Arjo (Huntleigh). Emerging players are Hyperice (Normatec) and Koya Medical. Mego Afek (Lymphapress International) is listed as a regional player.
Does LYMPHA PRESS, U.S.A. have an API?
No public API is recorded for LYMPHA PRESS, U.S.A..
What industry is LYMPHA PRESS, U.S.A. in?
LYMPHA PRESS, U.S.A.'s product category is Medical Compression Therapy Devices. Its primary akta.pro industry code is HLAHAMAH, Compression Therapy & Lymphedema DME (Garments, Pneumatic Pumps), with a secondary code of HSABADAI, Lymphedema & Edema Therapy In-Home. Its NAICS code is 333914 and its SIC code is 3845.